Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
gamma-aminobutyric acid type A receptor subunit beta1 | 0.686 | 0.500 | 0.98 |
|
disease | 0.340 | None | 1.000 | 5 | 0 | 1999 | 2006 | ||||||||
|
ankyrin repeat and kinase domain containing 1 | 0.604 | 0.462 | 7.4E-12 |
|
disease | 0.400 | None | 0.800 | 5 | 0 | 2004 | 2017 | ||||||||
|
gamma-aminobutyric acid type B receptor subunit 1 | 0.587 | 0.769 | 1.00 |
|
disease | 0.560 | None | 0.500 | 5 | 0 | 1999 | 2018 | ||||||||
|
solute carrier family 6 member 2 | 0.490 | 0.846 | 8.2E-02 |
|
disease | 0.330 | None | 0.800 | 5 | 0 | 2000 | 2012 | ||||||||
|
solute carrier family 6 member 3 | 0.453 | 0.885 | 1.00 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 1995 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 2C | 0.555 | 0.692 | 3.7E-02 |
|
disease | 0.360 | None | 0.200 | 5 | 0 | 1999 | 2004 | ||||||||
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
disease | 0.700 | None | 1.000 | 5 | 0 | 1999 | 2014 | ||||||||
|
tachykinin receptor 1 | 0.502 | 0.885 | 3.8E-04 |
|
disease | 0.550 | None | 1.000 | 5 | 0 | 2008 | 2014 | ||||||||
|
aldehyde dehydrogenase 1 family member A1 | 0.460 | 0.846 | 0.95 |
|
disease | 0.390 | None | 1.000 | 5 | 0 | 1983 | 2017 | ||||||||
|
monoamine oxidase A | 0.465 | 0.769 | 1.00 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 1995 | 2018 | ||||||||
|
monoamine oxidase B | 0.533 | 0.808 | 1.00 |
|
disease | 0.390 | None | 1.000 | 5 | 0 | 1994 | 2014 | ||||||||
|
cholinergic receptor muscarinic 2 | 0.585 | 0.615 | 0.18 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2004 | 2018 | ||||||||
|
cholinergic receptor nicotinic alpha 5 subunit | 0.593 | 0.577 | 2.1E-06 |
|
disease | 0.560 | None | 1.000 | 5 | 0 | 2009 | 2019 | ||||||||
|
alcohol dehydrogenase 1A (class I), alpha polypeptide | 0.647 | 0.577 | 1.7E-11 |
|
disease | 0.330 | None | 1.000 | 5 | 0 | 1999 | 2013 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.360 | None | 1.000 | 5 | 0 | 2001 | 2018 | ||||||||
|
aldo-keto reductase family 1 member A1 | 0.510 | 0.846 | 6.7E-07 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 1977 | 2019 | ||||||||
|
cannabinoid receptor 1 | 0.446 | 0.808 | 0.51 |
|
disease | 0.370 | None | 1.000 | 5 | 0 | 2002 | 2014 | ||||||||
|
opioid receptor kappa 1 | 0.555 | 0.615 | 4.1E-05 |
|
disease | 0.400 | None | 0.800 | 5 | 0 | 2004 | 2018 | ||||||||
|
cholinergic receptor nicotinic alpha 4 subunit | 0.492 | 0.808 | 8.5E-05 |
|
disease | 0.330 | None | 1.000 | 4 | 0 | 2005 | 2019 | ||||||||
|
cholinergic receptor nicotinic alpha 3 subunit | 0.588 | 0.692 | 1.4E-07 |
|
disease | 0.530 | None | 1.000 | 4 | 0 | 2009 | 2014 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 2A | 0.522 | 0.808 | 1.00 |
|
disease | 0.340 | None | 1.000 | 4 | 0 | 2008 | 2015 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.330 | None | 0.750 | 4 | 0 | 2005 | 2018 | ||||||||
|
taste 2 receptor member 38 | 0.531 | 0.808 | 0.13 |
|
disease | 0.540 | None | 0.750 | 4 | 0 | 1992 | 2010 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.340 | None | 0.750 | 4 | 0 | 2002 | 2008 | ||||||||
|
5-hydroxytryptamine receptor 3A | 0.608 | 0.538 | 1.7E-10 |
|
disease | 0.340 | None | 0.750 | 4 | 0 | 2009 | 2016 |